Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRYSTALLBrain: Normal Saline vs Lactated Ringer's in Subarachnoid Hemorrhage
NCT04043598Recruiting
- Sponsor
- Insel Gruppe
- Start
- May 2022
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium chloride and lactated ringer's solution in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Insel Gruppe. Primary endpoint: Clinically relevant vasospasms at 21 days. Started May 2022; status: recruiting.
02
Drugs
sodium chloridelactated ringer's solution
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04043598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043598.